The evolution of resistance to cephalosporins

被引:28
作者
Moosdeen, F
机构
[1] Department of Medical Microbiology, Faculty of Medical Sciences, University of the West Indies, Kingston
关键词
D O I
10.1093/clinids/24.3.487
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The expression of resistance to cephalosporins is highly varied and due to various mechanisms. The greatest disadvantage of the cephalosporins is that they are inactivated by the array of beta-lactamases produced by bacteria. The high levels of chromosomal enzymes produced by these organisms are a major cause of cephalosporin resistance, Plasmid-mediated beta-lactamases (PMBLs) have also been implicated as causes of resistance, and other cephalosporinases have been described, Point mutations of specific amino acids of well-recognized PMBLs (e.g., TEM-1 and SHV-1) have also produced enzymes capable of attacking a wider spectrum of beta-lactam agents. The availability of newer beta-lactams may be conducive to the development of such beta-lactamases, in which chromosomal and newer plasmid derivatives that may or may not contain the AmpC gene are selected. The occurrence of such enzymes is likely to continue to increase.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 77 条
[2]   EXTENDED BROAD-SPECTRUM BETA-LACTAMASE IN KLEBSIELLA PNEUMONIAE INCLUDING RESISTANCE TO CEPHAMYCINS [J].
BAUERNFEIND, A ;
CHONG, Y ;
SCHWEIGHART, S .
INFECTION, 1989, 17 (05) :316-321
[3]   PERMEABILITY AND PENICILLIN-BINDING PROTEIN ALTERATIONS IN SALMONELLA-MUENCHEN - STEPWISE RESISTANCE ACQUIRED DURING BETA-LACTAM THERAPY [J].
BELLIDO, F ;
VLADOIANU, IR ;
AUCKENTHALER, R ;
SUTER, S ;
WACKER, P ;
THEN, RL ;
PECHERE, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) :1113-1115
[4]   NUCLEOTIDE-SEQUENCE OF THE SHV-5 BETA-LACTAMASE GENE OF A KLEBSIELLA-PNEUMONIAE PLASMID [J].
BILLOTKLEIN, D ;
GUTMANN, L ;
COLLATZ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2439-2441
[5]   CHARACTERIZATION OF A NEW TEM-TYPE BETA-LACTAMASE RESISTANT TO CLAVULANATE, SULBACTAM, AND TAZOBACTAM IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
BLAZQUEZ, J ;
BAQUERO, MR ;
CANTON, R ;
ALOS, I ;
BAQUERO, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) :2059-2063
[6]   PLASMID-DETERMINED BETA-LACTAMASE INDISTINGUISHABLE FROM CHROMOSOMAL BETA-LACTAMASE OF ESCHERICHIA-COLI [J].
BOBROWSKI, MM ;
MATTHEW, M ;
BARTH, PT ;
DATTA, N ;
GRINTER, NJ ;
JACOB, AE ;
KONTOMICHALOU, P ;
DALE, JW ;
SMITH, JT .
JOURNAL OF BACTERIOLOGY, 1976, 125 (01) :149-157
[7]   CEFTAZIDIME RESISTANCE AMONG SELECTED NOSOCOMIAL GRAM-NEGATIVE BACILLI IN THE UNITED-STATES [J].
BURWEN, DR ;
BANERJEE, SN ;
GAYNES, RP .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1622-1625
[8]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[9]   NUCLEOTIDE-SEQUENCES OF CAZ-2, CAZ-6, AND CAZ-7 BETA-LACTAMASE GENES [J].
CHANAL, C ;
POUPART, MC ;
SIROT, D ;
LABIA, R ;
SIROT, J ;
CLUZEL, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :1817-1820
[10]   SUBSTITUTION OF SERINE FOR ARGININE IN POSITION-162 OF TEM-TYPE BETA-LACTAMASES EXTENDS THE SUBSTRATE PROFILE OF MUTANT ENZYMES, TEM-7 AND TEM-101, TO CEFTAZIDIME AND AZTREONAM [J].
COLLATZ, E ;
VANNHIEU, GT ;
BILLOTKLEIN, D ;
WILLIAMSON, R ;
GUTMANN, L .
GENE, 1989, 78 (02) :349-354